High-throughput chemo-transcriptomics for drug discovery

Dr. Tim Read, Co-Founder and CTO of Arpeggio Biosciences shares how the company has been able to develop the affordable automated RNA sequencing platform GRETA (Global Reporter on Transcript Abundance) that can efficiently generate 10’s of thousands of transcriptomes in a single experiment. During the presentation, Dr. Read also shares how the Echo acoustic liquid handler from Beckman Coulter Life Sciences plays an integral part to this assay.

This video was filmed at SLAS2024.